We use cookies for a better user experience. Read our Privacy Policy
I Agree
Hematology Diagnostics Market Trends, 2018-2026
Global Hematology Diagnostics Market - Snapshot
Hematology is defined as the diagnostic classification of cells present in the blood and resulting identification of diseases of the blood-forming organs and diseases of the blood. It includes the calculation of WBC, RBC, and platelets. The analysis for hematologic disorders is related to disease monitoring, prognosis, diagnosis, and screening. Rise in prevalence of blood disorders, technological advancements and introduction of new technically advanced fully automated hematology analyzers, significant demand for laboratory automation, and increase in consolidation among market players and diagnostic laboratories are key factors that are expected to drive the global hematology diagnostics market during the forecast period.
The hematology diagnostics market can be segmented based on product type, which includes hematology instruments and hematology consumables. In terms of revenue, the global hematology diagnostics market was valued at approximately US$ 3,495.0 Mn in 2017 and is anticipated to reach approximately US$ 5,586.4 Mn by 2026, expanding at a CAGR of more than 5.0% from 2018 to 2026. The expansion of hematology consumables segment is likely to fuel the growth of global hematology diagnostics from 2018 to 2026. Rapid expansion of the global hematology diagnostics market is attributed to the increase in prevalence of blood disorders. Rise in awareness about these disorders among health care professionals and patients is projected to increase the demand for hematology diagnostics. For instance, approximately every three minutes, one person in the U.S. is diagnosed with blood cancer. Nearly 172,910 people in the U.S. were diagnosed with leukemia, lymphoma, or myeloma, in 2017. New cases of leukemia, lymphoma, and myeloma are expected to account for 10.2% of the estimated 1,688,780 new cancer cases diagnosed in the U.S. in 2017. An estimated 1,290,773 people in the U.S. are either living with, or are in remission from, leukemia, lymphoma, or myeloma.
Hematology testing devices have come a long way from disease detection and monitoring to counting and characterizing blood cells. The concept of automation has extended to detect small cell populations in order to diagnose rare blood conditions, which requires less labor, rapid result, and easy-to-use analyzers. Current technologies include automation of hematology analyzer, electrical impedance, flow cytometry, and fluorescent flow. Combination of these technologies has increased the yield and productivity of test results. Test volume, i.e. number of tests performed, is projected to increase owing to technological advances in disease diagnosis and the rise in demand for preventive diagnosis and treatment monitoring. This is also augmenting the demand for hematology analyzers with high throughput. Such technological revolution in hematology testing is expected to propel the market during the forecast period.
Hematology diagnostics market is witnessing expansion. Key market players such as Abbott Laboratories, Sysmex Corporation, F. Hoffmann-La Roche Ltd., and Beckman Coulter, Inc. have a strong presence in the global hematology diagnostics market. The global hematology diagnostics market has witnessed high investments by various multinational manufacturers such, Abbott Laboratories, Sysmex Corporation and F. Hoffmann-La Roche Ltd in the last few years. The hematology diagnostics market is driven by significant demand for laboratory automation and consolidation in order to improve precision and efficiency, and advancement in technology leading to easy usage. For example, in April 2018, Danaher (Beckman Coulter, Inc.) received CE Mark of its DxH 520 hematology analyzer, which is designed to help physician office laboratories. Another example, in January 2017, Roche announced the launch of the new, hematology testing solution, the Cobas m 511 integrated hematology analyzer. Cobas m 511, uses a unique approach through patented Bloodhound technology for printing, staining, and imaging.
The global hematology diagnostics has been segmented based on product type, end-user, and geography. Based on product type, the market has been split into hematology instruments and hematology consumables. The hematology consumables segment led the market and is expected to continue its dominance during the forecast period. Factors such as rise in awareness of blood disorders among health care professionals and patients are projected to increase the demand for hematology analyzers and consumables. The hematology instruments segment is likely to lose market share during the forecast period. Among the hematology instruments segment, hematology analyzers was the leading sub-segment in 2017. The sub-segment is likely to account for a leading share of the segment of the market during the forecast period. Among the hematology consumables segment, reagents segment was the leading sub-segment in year 2017. It is and anticipated to dominate the segment of the market during the forecast period.
In terms of geography, North America held a major share of the global hematology diagnostics market in 2017. Technological advancements in instruments, ease of usage, and favorable reimbursement scenario drives the hematology diagnostics market in the region. The U.S. and Canada are rapidly advancing the frontiers of research and technological development as well as setting stringent standards for analysis of blood products quality. This, in turn, is likely to propel the hematology diagnostics market in North America during the forecast period. Asia Pacific is witnessing rapid development. High per capita income has increased utilization of diagnostic and therapy products in the region. Rapid expansion of the market in the region can be attributed to numerous government initiatives undertaken to improve the health care infrastructure. Development of health care infrastructure, rise in population, boom in the biotechnology industry, and increase in burden of diseases requiring diagnostic tests are propelling the hematology diagnostics market in Latin America and Middle East & Africa.
Key companies operating in the global hematology diagnostics and profiled in the report include Abbott Laboratories, Sysmex Corporation, F. Hoffmann-La Roche Ltd., and Beckman Coulter, Inc. These players are adopting advanced techniques to develop hematology diagnostics and in order to expand their product offerings, strengthen their geographical reach, increase customer base, and garner market share. For instance, in June 2017, Abbott Laboratories announced the availability of Sekisui’s CP3000 coagulation analyzer in Europe, the Middle East, and Asia Pacific. In another instance, in March 2015, the diagnostics division of Siemens Healthineers launched three new scalable hematology systems: ADVIA 360 System, ADVIA 560 System, and ADVIA 560 AL System.
Hematology diagnostics market was valued at approximately US$ 3,495.0 Mn in 2017 and is anticipated to reach approximately US$ 5,586.4 Mn by 2026
Hematology diagnostics market will exhibit a healthy 5.0% CAGR over the period between 2018 and 2026
Hematology diagnostics market is driven by rise in prevalence of blood disorders, technological advancements and introduction of new technically advanced fully automated hematology analyzers
The hematology consumables segment led the hematology diagnostics market and is expected to continue its dominance during the forecast period
Key players operating in the global hematology diagnostics and profiled in the report include Abbott Laboratories, Sysmex Corporation, F. Hoffmann-La Roche Ltd., and Beckman Coulter, Inc.
Section 01 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights
Section 02 Assumptions and Research Methodology
2.1 Assumptions
2.2 Research Methodology
Section 03 Executive Summary
3.1 Global Hematology Diagnostics Market Size (US$ Mn) and Distribution by Geography, 2017 and 2026
3.2 Global Hematology Diagnostics Market Snapshot, 2017
3.3 Global Hematology Diagnostics Market: Opportunity Map
Section 04 Market Overview
4.1 Overview
4.2 Global Hematology Diagnostics Market Size (US$ Mn) Forecast, 2016–2026
4.3 Global Hematology Diagnostics Market Outlook
4.4 Global Hematology Diagnostics Market: Porter’s Five Forces Analysis
4.5 Hematology Analyzers Installed Base
4.6 Key Success factor for Top 3 Players
4.7 Technological Advancements
4.8 Disease Prevalence & Incidence Rate Globally with Key Countries
Section 05 Market Dynamics
5.1 Drivers
5.2 Restraints
5.3 Opportunity Analysis
5.4 Opportunities
5.5 Trends
Section 06 Hematology Diagnostics Market Analysis, by Product Type
6.1 Introduction
6.2 Global Hematology Diagnostics Market Value Share Analysis, by Product Type
6.3 Hematology Diagnostics Market Analysis, by Product Type
6.3.1 Hematology Instruments
6.3.1.1 Hematology Analyzers
6.3.1.1.1 Fully-automated Hematology Analyzers
6.3.1.1.2 Semi-automated Hematology Analyzers
6.3.1.2 Flow Cytometers
6.3.1.3 Others
6.3.2 Hematology Consumables
6.3.2.1 Reagents
6.3.2.2 Stains
6.3.2.3 Controls & Calibrators
6.3.2.4 Others
6.4 Hematology Diagnostics Market Attractiveness Analysis, by Product Type
6.5 Hematology Diagnostics Market Attractiveness Analysis, by Hematology Analyzers
6.6 Hematology Diagnostics Market Attractiveness Analysis, by Hematology Consumables
Section 07 Hematology Diagnostics Market Analysis, by End-user
7.1 Introduction
7.2 Global Hematology Diagnostics Market Value Share Analysis, by End-user
7.3 Hematology Diagnostics Market Analysis, by End-user
7.3.1 Diagnostic Laboratories
7.3.2 Hospitals & Clinics
7.3.3 Academic Institutes
7.3.4 Others
7.4 Hematology Diagnostics Market Attractiveness Analysis, by End-user
Section 08 Hematology Diagnostics Market Analysis, by Region
8.1 Global Hematology Diagnostics Market Snapshot, by Country
8.2 Global Hematology Diagnostics Market Value Share Analysis, by Region
8.3 Hematology Diagnostics Market Forecast, by Region
8.3.1 North America
8.3.2 Europe
8.3.3 Asia Pacific
8.3.4 Latin America
8.3.5 Middle East & Africa
8.4 Hematology Diagnostics Market Attractiveness Analysis, by Region
8.5 Hematology Diagnostics Market: Regional Trends
Section 09 North America Hematology Diagnostics Market Analysis
9.1 Key Findings
9.2 North America Hematology Diagnostics Market Overview
9.3 North America Market Value Share Analysis, by Product Type
9.4 North America Market Forecast, by Product Type
9.4.1 Hematology Instruments
9.4.2 Hematology Consumables
9.5 North America Market Value Share Analysis, by Hematology Instruments
9.6 North America Market Forecast, by Hematology Instruments
9.6.1 Hematology Analyzers
9.6.2 Flow Cytometers
9.6.3 Others
9.7 North America Market Value Share Analysis, by Hematology Consumables
9.8 North America Market Forecast, by Hematology Consumables
9.8.1 Reagents
9.8.2 Stains
9.8.3 Controls & Calibrators
9.8.4 Others
9.9 North America Market Value Share Analysis, by End-user
9.10 North America Market Forecast, by End-user
9.10.1 Diagnostic Laboratories
9.10.2 Hospitals & Clinics
9.10.3 Academic Institutes
9.10.4 Others
9.11 Market Analysis, by Country
9.12 Market Value Share Analysis, by Country
9.13 Market Size (US$ Mn) Forecast, by Country, 2018–2026
9.13.1 U.S.
9.13.2 Canada
9.14 Market Attractiveness Analysis
9.14.1 by Product Type
9.14.2 by Hematology Instruments
9.14.3 by Hematology Consumables
9.14.4 by End-user
9.14.5 by Country
Section 10 Europe Hematology Diagnostics Market Analysis
10.1 Key Findings
10.2 Europe Hematology Diagnostics Market Overview
10.3 Europe Market Value Share Analysis, by Product Type
10.4 Europe Market Forecast, by Product Type
10.4.1 Hematology Instruments
10.4.2 Hematology Consumables
10.5 Europe Market Value Share Analysis, by Hematology Instruments
10.6 Europe Market Forecast, by Hematology Instruments
10.6.1 Hematology Analyzers
10.6.2 Flow Cytometers
10.6.3 Others
10.7 Europe Market Value Share Analysis, by Hematology Consumables
10.8 Europe Market Forecast, by Hematology Consumables
10.8.1 Reagents
10.8.2 Stains
10.8.3 Controls & Calibrators
10.8.4 Others
10.9 Europe Market Value Share Analysis, by End-user
10.10 Europe Market Forecast, by End-user
10.10.1 Diagnostic Laboratories
10.10.2 Hospitals & Clinics
10.10.3 Academic Institutes
10.10.4 Others
10.11 Market Analysis, by Country
10.12 Market Value Share Analysis, by Country
10.13 Market Size (US$ Mn) Forecast, by Country, 2018–2026
10.13.1 Germany
10.13.2 France
10.13.3 U.K.
10.13.4 Italy
10.13.5 Spain
10.13.6 Rest of Europe
10.14 Market Attractiveness Analysis
10.14.1 by Product Type
10.14.2 by Hematology Instruments
10.14.3 by Hematology Consumables
10.14.4 by End-user
10.14.5 by Country
Section 11 Asia Pacific Hematology Diagnostics Market Analysis
11.1 Key Findings
11.2 Asia Pacific Hematology Diagnostics Market Overview
11.3 Asia Pacific Market Value Share Analysis, by Product Type
11.4 Asia Pacific Market Forecast, by Product Type
11.4.1 Hematology Instruments
11.4.2 Hematology Consumables
11.5 Asia Pacific Market Value Share Analysis, by Hematology Instruments
11.6 Asia Pacific Market Forecast, by Hematology Instruments
11.6.1 Hematology Analyzers
11.6.2 Flow Cytometers
11.6.3 Others
11.7 Asia Pacific Market Value Share Analysis, by Hematology Consumables
11.8 Asia Pacific Market Forecast, by Hematology Consumables
11.8.1 Reagents
11.8.2 Stains
11.8.3 Controls & Calibrators
11.8.4 Others
11.9 Asia Pacific Market Value Share Analysis, by End-user
11.10 Asia Pacific Market Forecast, by End-user
11.10.1 Diagnostic Laboratories
11.10.2 Hospitals & Clinics
11.10.3 Academic Institutes
11.10.4 Others
11.11 Market Analysis, by Country
11.12 Market Value Share Analysis, by Country
11.13 Market Size (US$ Mn) Forecast, by Country, 2018–2026
11.13.1 China
11.13.2 Japan
11.13.3 India
11.13.4 Australia & New Zealand
11.13.5 Rest of Asia Pacific
11.14 Market Attractiveness Analysis
11.14.1 by Product Type
11.14.2 by Hematology Instruments
11.14.3 by Hematology Consumables
11.14.4 by End-user
11.14.5 by Country
Section 12 Latin America Hematology Diagnostics Market Analysis
12.1 Key Findings
12.2 Latin America Hematology Diagnostics Market Overview
12.3 Latin America Market Value Share Analysis, by Product Type
12.4 Latin America Market Forecast, by Product Type
12.4.1 Hematology Instruments
12.4.2 Hematology Consumables
12.5 Latin America Market Value Share Analysis, by Hematology Instruments
12.6 Latin America Market Forecast, by Hematology Instruments
12.6.1 Hematology Analyzers
12.6.2 Flow Cytometers
12.6.3 Others
12.7 Latin America Market Value Share Analysis, by Hematology Consumables
12.8 Latin America Market Forecast, by Hematology Consumables
12.8.1 Reagents
12.8.2 Stains
12.8.3 Controls & Calibrators
12.8.4 Others
12.9 Latin America Market Value Share Analysis, by End-user
12.10 Latin America Market Forecast, by End-user
12.10.1 Diagnostic Laboratories
12.10.2 Hospitals & Clinics
12.10.3 Academic Institutes
12.10.4 Others
12.11 Market Analysis, by Country
12.12 Market Value Share Analysis, by Country
12.13 Market Size (US$ Mn) Forecast, by Country, 2018–2026
12.13.1 Brazil
12.13.2 Mexico
12.13.3 Rest of Latin America
12.14 Market Attractiveness Analysis
12.14.1 by Product Type
12.14.2 by Hematology Instruments
12.14.3 by Hematology Consumables
12.14.4 by End-user
12.14.5 by Country
Section 13 Middle East & Africa Hematology Diagnostics Market Analysis
13.1 Key Findings
13.2 Middle East & Africa Hematology Diagnostics Market Overview
13.3 Middle East & Africa Market Value Share Analysis, by Product Type
13.4 Middle East & Africa Market Forecast, by Product Type
13.4.1 Hematology Instruments
13.4.2 Hematology Consumables
13.5 Middle East & Africa Market Value Share Analysis, by Hematology Instruments
13.6 Middle East & Africa Market Forecast, by Hematology Instruments
13.6.1 Hematology Analyzers
13.6.2 Flow Cytometers
13.6.3 Others
13.7 Middle East & Africa Market Value Share Analysis, by Hematology Consumables
13.8 Middle East & Africa Market Forecast, by Hematology Consumables
13.8.1 Reagents
13.8.2 Stains
13.8.3 Controls & Calibrators
13.8.4 Others
13.9 Middle East & Africa Market Value Share Analysis, by End-user
13.10 Middle East & Africa Market Forecast, by End-user
13.10.1 Diagnostic Laboratories
13.10.2 Hospitals & Clinics
13.10.3 Academic Institutes
13.10.4 Others
13.11 Market Analysis, by Country
13.12 Market Value Share Analysis, by Country
13.13 Market Size (US$ Mn) Forecast, by Country, 2018–2026
13.13.1 GCC Countries
13.13.2 South Africa
13.13.3 Rest of Middle East & Africa
13.14 Market Attractiveness Analysis
13.14.1 By Product Type
13.14.2 by Hematology Instruments
13.14.3 by Hematology Consumables
13.14.4 by End-user
13.14.5 by Country
Section 14 Competition Landscape
14.1 Competition Matrix
14.2 Hematology Diagnostics Market Share Analysis, by Company (2017)
14.3 Company Profiles
14.3.1 Abbott Laboratories
14.3.1.1 Company Description
14.3.1.2 Financial Overview
14.3.1.3 Strategy & Recent Developments
14.3.1.4 SWOT Analysis
14.3.2 Bio-Rad Laboratories, Inc.
14.3.2.1 Company Description
14.3.2.2 Financial Overview
14.3.2.3 Strategy & Recent Developments
14.3.2.4 SWOT Analysis
14.3.3 Sysmex Corporation
14.3.3.1 Company Description
14.3.3.2 Financial Overview
14.3.3.3 Strategy & Recent Developments
14.3.3.4 SWOT Analysis
14.3.4 Mindray Medical International Limited
14.3.4.1 Company Description
14.3.4.2 Financial Overview
14.3.4.3 Strategy & Recent Developments
14.3.4.4 SWOT Analysis
14.3.5 Siemens Healthineers
14.3.5.1 Company Description
14.3.5.2 Financial Overview
14.3.5.3 Strategy & Recent Developments
14.3.5.4 SWOT Analysis
14.3.6 F. Hoffmann-La Roche Ltd.
14.3.6.1 Company Description
14.3.6.2 Financial Overview
14.3.6.3 Strategy & Recent Developments
14.3.6.4 SWOT Analysis
14.3.7 HORIBA, Ltd.
14.3.7.1 Company Description
14.3.7.2 Financial Overview
14.3.7.3 Strategy & Recent Developments
14.3.7.4 SWOT Analysis
14.3.8 HemoCue AB
14.3.8.1 Company Description
14.3.8.2 Financial Overview
14.3.8.3 Strategy & Recent Developments
14.3.8.4 SWOT Analysis
14.3.9 Danaher (Beckman Coulter, Inc.)
14.3.9.1 Company Description
14.3.9.2 Financial Overview
14.3.9.3 Strategy & Recent Developments
14.3.9.4 SWOT Analysis
List of Tables
Table 01: Global Hematology diagnostics Market Analysis, by Installed Base
Table 02: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 03: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2026
Table 04: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2026
Table 05: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2026
Table 06: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 07: Global Hematology Diagnostics Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 08: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 09: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 10: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2026
Table 11: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2026
Table 12: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2026
Table 13: North America Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 14: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 15: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 16: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2026
Table 17: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2026
Table 18: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2026
Table 19: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 20: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 21: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 22: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2026
Table 23: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2026
Table 24: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2026
Table 25: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 26: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 27: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 28: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2026
Table 29: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2026
Table 30: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2026
Table 31: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 32: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 33: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 34: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2026
Table 35: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2026
Table 36: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2026
Table 37: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2016–2026
List of Figures
Figure 01: Global Hematology Diagnostics Market Size (US$ Mn) and Distribution, by Region, 2017 and 2026
Figure 02: Global Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 03: Hematology Diagnostics Market Value Share, by Product Type, 2017
Figure 04: Hematology Diagnostics Market Value Share, by Hematology Consumables, 2017
Figure 05: Hematology Diagnostics Market Value Share, by Hematology Instruments, 2017
Figure 06: Hematology Diagnostics Market Value Share, by Region, 2017
Figure 07: Expected New Cases of Leukemia, Lymphoma, or Myeloma in 2017
Figure 08: Global Hematology Diagnostics Market Value Share, by Product Type, 2017 and 2026
Figure 09: Global Hematology Diagnostics Market Value Share, by Hematology Instruments, 2017 and 2026
Figure 10: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hematology Analyzers, 2016–2026
Figure 11: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Flow Cytometers, 2016–2026
Figure 12: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 13: Global Hematology Diagnostics Market Value Share, by Hematology Consumables, 2017 and 2026
Figure 14: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Reagents, 2016–2026
Figure 15: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Stains, 2016–2026
Figure 16: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Controls & Calibrators, 2016–2026
Figure 17: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 19: Global Hematology Diagnostics Market Attractiveness Analysis, by Hematology Instruments, 2018–2026
Figure 18: Global Hematology Diagnostics Market Attractiveness Analysis, by Product Type, 2018–2026
Figure 20: Global Hematology Diagnostics Market Attractiveness Analysis, by Hematology Consumables, 2018–2026
Figure 21: Global Hematology Diagnostics Market Value Share, by End-user, 2017 and 2026
Figure 22: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2016–2026
Figure 23: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals & Clinics, 2016–2026
Figure 24: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academic Institutes, 2016–2026
Figure 25: Global Hematology Diagnostics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 26: Global Hematology Diagnostics Market Attractiveness Analysis, by End-user, 2018–2026
Figure 27: Global Hematology Diagnostics Market Value Share, by Region, 2017 and 2026
Figure 28: Global Hematology Diagnostics Market Attractiveness Analysis, by Region, 2018–2026
Figure 29: North America Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 30: North America Hematology Diagnostics Market Value Share, by Country, 2017 and 2026
Figure 31: North America Hematology Diagnostics Market Attractiveness, by Country, 2018–2026
Figure 32: North America Hematology Diagnostics Market Value Share, by Product Type, 2017 and 2026
Figure 33: North America Hematology Diagnostics Market Attractiveness, by Product Type, 2018–2026
Figure 34: North America Hematology Diagnostics Market Value Share, by Hematology Instruments, 2017 and 2026
Figure 35: North America Hematology Diagnostics Market Attractiveness, by Hematology Instruments, 2018–2026
Figure 36: North America Hematology Diagnostics Market Value Share, by Hematology Consumables, 2017 and 2026
Figure 37: North America Hematology Diagnostics Market Attractiveness, by Hematology Consumables, 2018–2026
Figure 38: North America Hematology Diagnostics Market Value Share, by End-user, 2017 and 2026
Figure 39: North America Hematology Diagnostics Market Attractiveness, by End-user, 2018–2026
Figure 40: Europe Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 41: Europe Hematology Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 42: Europe Hematology Diagnostics Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 43: Europe Hematology Diagnostics Market Value Share, by Product Type, 2017 and 2026
Figure 44: Europe Hematology Diagnostics Market Attractiveness, by Product Type, 2018–2026
Figure 45: Europe Hematology Diagnostics Market Value Share, by Hematology Instruments, 2017 and 2026
Figure 46: Europe Hematology Diagnostics Market Attractiveness, by Hematology Instruments, 2018–2026
Figure 47: Europe Hematology Diagnostics Market Value Share, by Hematology Consumables, 2017 and 2026
Figure 48: Europe Hematology Diagnostics Market Attractiveness, by Hematology Consumables, 2018–2026
Figure 49: Europe Hematology Diagnostics Market Value Share, by End-user, 2017 and 2026
Figure 50: Europe Hematology Diagnostics Market Attractiveness, by End-user, 2018–2026
Figure 51: Asia Pacific Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 52: Asia Pacific Hematology Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 53: Asia Pacific Hematology Diagnostics Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 54: Asia Pacific Hematology Diagnostics Market Value Share, by Product Type, 2017 and 2026
Figure 55: Asia Pacific Hematology Diagnostics Market Attractiveness, by Product Type, 2018–2026
Figure 56: Asia Pacific Hematology Diagnostics Market Value Share, by Hematology Instruments, 2017 and 2026
Figure 57: Asia Pacific Hematology Diagnostics Market Attractiveness, by Hematology Instruments, 2018–2026
Figure 58: Asia Pacific Hematology Diagnostics Market Value Share, by Hematology Consumables, 2017 and 2026
Figure 59: Asia Pacific Hematology Diagnostics Market Attractiveness, by Hematology Consumables, 2018–2026
Figure 60: Asia Pacific Hematology Diagnostics Market Value Share, by End-user, 2017 and 2026
Figure 61: Europe Hematology Diagnostics Market Attractiveness, by End-user, 2018–2026
Figure 62: Latin America Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 63: Latin America Hematology Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 64: Latin America Hematology Diagnostics Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 65: Latin America Hematology Diagnostics Market Value Share, by Product Type, 2017 and 2026
Figure 66: Latin America Hematology Diagnostics Market Attractiveness, by Product Type, 2018–2026
Figure 67: Latin America Hematology Diagnostics Market Attractiveness, by Hematology Instruments, 2018–2026
Figure 68: Latin America Hematology Diagnostics Market Value Share, by Hematology Instruments, 2017 and 2026
Figure 69: Latin America Hematology Diagnostics Market Value Share, by Hematology Consumables, 2017 and 2026
Figure 70: Latin America Hematology Diagnostics Market Attractiveness, by Hematology Consumables, 2018–2026
Figure 71: Latin America Hematology Diagnostics Market Value Share, by End-user, 2017 and 2026
Figure 72: Latin America Hematology Diagnostics Market Attractiveness, by End-user, 2018–2026
Figure 73: Middle East & Africa Hematology Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 74: Middle East & Africa Hematology Diagnostics Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 75: Middle East & Africa Hematology Diagnostics Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 76: Middle East & Africa Hematology Diagnostics Market Value Share, by Product Type, 2017 and 2026
Figure 77: Middle East & Africa Hematology Diagnostics Market Attractiveness, by Product Type, 2018–2026
Figure 78: Middle East & Africa Hematology Diagnostics Market Value Share, by Hematology Instruments, 2017 and 2026
Figure 79: Middle East & Africa Hematology Diagnostics Market Attractiveness, by Hematology Instruments, 2018–2026
Figure 80: Middle East & Africa Hematology Diagnostics Market Value Share, by Hematology Consumables, 2017 and 2026
Figure 81: Middle East & Africa Hematology Diagnostics Market Attractiveness, by Hematology Consumables, 2018–2026
Figure 82: Middle East & Africa Hematology Diagnostics Market Value Share, by End-user, 2017 and 2026
Figure 83: Middle East & Africa Hematology Diagnostics Market Attractiveness, by End-user, 2018–2026
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
*86 figures and 60 tables includes